People With Mental Disorders Less Likely to Complete CRC Screening
THURSDAY, Aug. 3, 2023 (HealthDay News) — People with mental disorders are less likely to participate in colorectal cancer screening versus those without these disorders, according to a study published in the July issue of The Lancet Psychiatry.Mette…
Learn MoreACP: Screening Average-Risk Adults for Colorectal Cancer Should Start at 50 Years
MONDAY, July 31, 2023 (HealthDay News) — For asymptomatic average-risk patients, clinicians should start screening for colorectal cancer (CRC) at age 50 years, according to updated guidance from the American College of Physicians (ACP) published onli…
Learn MoreFruquintinib Provides Meaningful Benefit in Refractory Metastatic CRC
THURSDAY, July 20, 2023 (HealthDay News) — For patients with refractory metastatic colorectal cancer, fruquintinib treatment yields a significant and clinically meaningful benefit in terms of overall survival, according to a study published in the Ju…
Learn MoreGastrointestinal Cancers: Screening, Treatments & More
Gastrointestinal cancers can be some of the most deadly types of tumors, but screening and treatments can make a difference.Here’s a rundown on the types of gastrointestinal cancers, along with their symptoms, treatments and tips for prevention.Gastro…
Learn MoreRisk Factors Identified for Early-Onset Sporadic Colorectal Cancer
MONDAY, July 3, 2023 (HealthDay News) — Risk factors for early-onset colorectal cancer (EOCRC) have been identified in a study published online June 6 in Cancer Prevention Research.Thomas F. Imperiale, M.D., from the Richard L. Roudebush VA Medical C…
Learn MoreDoubling Up on FIT Testing Catches More Colorectal Cancers
MONDAY, June 12, 2023 (HealthDay News) — A double fecal immunochemical test (FIT) improves sensitivity and cuts the number of missed colorectal cancers, according to a study published online in the April issue of the British Journal of Surgery.Adam G…
Learn MoreLocally Recurrent Rectal Cancer QoL Is Valid Patient-Reported Outcome Measure
FRIDAY, June 9, 2023 (HealthDay News) — A new locally recurrent rectal cancer (LRRC) quality of life (QoL) measure is a valid patient-reported outcome measure (PROM), according to a study published in the May issue of eClinicalMedicine.Deena P. Harji…
Learn MoreASCO: FOLFOX Noninferior to Chemoradiotherapy for Overall Survival in Rectal Cancer
FRIDAY, June 9, 2023 (HealthDay News) — Neoadjuvant chemotherapy with fluorouracil, leucovorin, and oxaliplatin (FOLFOX) is noninferior to preoperative chemoradiotherapy with respect to overall survival for patients with locally advanced rectal cance…
Learn MoreCan Some Cancer Patients Safely Skip Radiation Therapy? New Studies Say Yes
TUESDAY, June 6, 2023 (HealthDay News) — Radiation therapy might not be necessary in treating some forms of rectal cancer and lymphoma, sparing patients from the toxic treatment, a pair of new clinical trials shows.One trial found that rectal cancer …
Learn MoreASCO: Microbiome Varies for Early-Onset, Late-Onset Colorectal Cancer
FRIDAY, June 2, 2023 (HealthDay News) — The microbiome (MB) of patients with colorectal cancer (CRC) varies between those diagnosed with early- or late-onset disease, according to a study presented at the annual meeting of the American Society of Cli…
Learn More